In a study of 306 COVID-19 positive subjects, it has been found that high plasma ACE2 during admission was associated with increased maximal illness severity within 28 days (OR = 1.8, 95%-CI: 1.4–2.3, p < 0.0001). This evidence concerns the gene ACE2 and COVID-19.